但是一些心脏病学家对该结果的有效性提出置疑,因为该研究有25%的非劣效性。
Some cardiologists, however, have questioned the validity of the results, since the study included a 25-percent margin for claiming "noninferiority" for Angiomax.
另外,对照的设立应结合考虑RCT研究的目的和设计,如非劣效性、等效性、优效性试验。
Besides, the selection of controls must focus on the design and aim of RCTs, such as non-inferiority, equivalence and superiority trials.
紫杉醇与S-1作为转移性乳腺癌的一线化疗(选择BC):一项开放标签、非劣效性、随机3期试验。
Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
应用推荐